← Open Payments lookup

AARON HOLDERMAN: Open Payments

NPI 1871863852 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,965 in 77 payments from 20 companies in 2025. Trend: 2023 $1,447 · 2024 $2,104 · 2025 $1,965

Food & beverage: $1,965
CompanyPaymentsAmount
ABBVIE INC.21$414
Janssen Biotech, Inc.9$287
Madrigal Pharmaceuticals6$235
Takeda Pharmaceuticals U.S.A., Inc.9$212
Regeneron Healthcare Solutions, Inc.2$136
GENZYME CORPORATION4$121
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$93
Gilead Sciences, Inc.3$81
Lilly USA, LLC3$63
QOL Medical, LLC3$63

Products named: TREMFYA, REZDIFFRA, ENTYVIO, RINVOQ, DUPIXENT, EYLEA HD, XIFAXAN, SKYRIZI.

Industry payments across IN — which companies pay providers there.